微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 7.95% | -18.55% | 42.99% | 34/128 | 4.74% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 5.56% | -9.89% | 114.67% | 28/128 | 3.02% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 2.59% | 21.6% | -72.77% | 38/128 | 1.68% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 9.51% | -20.88% | -2.56% | 34/128 | 4.98% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 9.76% | -25.78% | 58.18% | 27/128 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 6.17% | 21.22% | 189.67% | 32/128 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 2.13% | -8.58% | -82.28% | 54/128 | 2.29% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 12.02% | 247.4% | -8.59% | 56/128 | 13.37% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 13.15% | 84.95% | 158.35% | 38/128 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 5.09% | 27.57% | 118.45% | 67/128 | 9.31% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 2.33% | 44.72% | -32.66% | 64/128 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 3.46% | -48.13% | -51.34% | 110/128 | 17.51% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 7.11% | -21.95% | 78.2% | 79/128 | 15.94% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 3.99% | -30.24% | 147.83% | 90/128 | 11.54% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 1.61% | -32.07% | -75.86% | 83/128 | 6.23% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 6.67% | -21.9% | -26.78% | 99/128 | 25.89% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 9.11% | 14.74% | 59.27% | 53/128 | 19.85% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 5.72% | 24.62% | 141.35% | 66/128 | 15.16% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 2.37% | 28.11% | -72.25% | 37/128 | 3.4% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 8.54% | -22.71% | 7.56% | 83/128 | 14.36% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 7.94% | -23.36% | 72.98% | 40/128 | 10.49% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 4.59% | -25.37% | 148.11% | 48/128 | 6.73% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 1.85% | -56.78% | -83.26% | 33/128 | 2.72% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 11.05% | -39.88% | 6.66% | 64/128 | 12.98% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 10.36% | -35.37% | 68.46% | 21/128 | 7.16% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 6.15% | -7.24% | 43.69% | 22/128 | 3.21% | 明德生物 | 14.54% | 行业排名> |
| 2018-03-31 | 4.28% | 23.7% | -76.71% | 13/128 | 2.62% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 18.38% | 115.22% | 14.66% | 35/128 | 13.82% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 16.03% | 65.77% | 141.78% | 9/128 | 9.43% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 6.63% | 26.29% | 91.62% | 25/128 | 5.9% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 3.46% | -0.57% | -59.48% | 14/128 | 2.66% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 8.54% | -23.34% | -11.69% | 57/128 | 16.21% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 9.67% | -0.31% | 84.19% | 15/128 | 8.69% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 5.25% | -9.33% | 50.86% | 26/128 | 6.26% | 明德生物 | 23.29% | 行业排名> |
| 2016-03-31 | 3.48% | 35.41% | -68.76% | 7/128 | 2.14% | 健帆生物 | 7.75% | 行业排名> |
| 2015-12-31 | 11.14% | -37.83% | 14.85% | 38/128 | 15.95% | 大博医疗 | 55.39% | 行业排名> |
| 2015-09-30 | 9.7% | -25.67% | 67.53% | 11/128 | 7.79% | 鱼跃医疗 | 17.33% | 行业排名> |
| 2015-06-30 | 5.79% | -22.07% | 125.29% | 23/128 | 7.77% | 明德生物 | 29.93% | 行业排名> |
| 2015-03-31 | 2.57% | -7.22% | -85.66% | 17/128 | 3.2% | 中源协和 | 14.44% | 行业排名> |
| 2014-12-31 | 17.92% | 3.17% | 37.32% | 23/128 | 17.21% | 明德生物 | 71.37% | 行业排名> |
| 2014-09-30 | 13.05% | 3.9% | 75.64% | 7/128 | 9.2% | 美康生物 | 30.15% | 行业排名> |
| 2014-06-30 | 7.43% | -1.98% | 168.23% | 10/128 | 7.24% | 明德生物 | 39.25% | 行业排名> |
| 2014-03-31 | 2.77% | 2% | -84.05% | 8/128 | 2.07% | 楚天科技 | 6.51% | 行业排名> |